Clinical Trials: Antihypertensive Agents
- Alfuzosin 48 studies
- Amlodipine, atorvastatin drug combination 15 studies
- Amlodipine, valsartan drug combination 20 studies
- Angiotensin I (1-7) 13 studies
- Benazepril 38 studies
- Bimatoprost 78 studies
- Bosentan 79 studies
- BQ 788 3 studies
- Brimonidine 77 studies
- Candesartan 98 studies
- Candesartan cilexetil 98 studies
- Carvedilol 109 studies
- Cycletanide 1 study
- Cyclo(Trp-Asp-Pro-Val-Leu) 11 studies
- Dorzolamide 49 studies
- Eprosartan 6 studies
- Essential 303 forte 1 study
- Ferulic acid 1 study
- Hydrochlorothiazide, lisinopril drug combination 1 study
- Imidapril 3 studies
- Indapamide, perindopril drug combination 2 studies
- Irbesartan 76 studies
- Isopropyl unoprostone 1 study
- Lacidipine 5 studies
- Latanoprost 150 studies
- Lercanidipine 9 studies
- Lofexidine 13 studies
- Manidipine 3 studies
- Moxonidine 11 studies
- N(1),N(11)-diethylnorspermine 2 studies
- N(1),N(14)-bis(ethyl)homospermine 1 study
- Naftopidil 2 studies
- Nebivolol 63 studies
- Olmesartan medoxomil 87 studies
- Quinapril 22 studies
- Rilmenidine 1 study
- Terlipressin 23 studies
- Tibolone 20 studies
- Tocopherylquinone 2 studies
- Torsemide 12 studies
- Trandolapril 18 studies
- Travoprost 95 studies
- Treprostinil 52 studies
- Urapidil 6 studies
- Valsartan 205 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_AnAg
